| dbo:abstract |
Clevidipin ist ein Arzneistoff (ein Dihydropyridin-L-Typ-Calciumkanalblocker) aus der Gruppe der Calciumantagonisten zur raschen Reduktion eines erhöhten Blutdrucks in perioperativen Situationen. Die Substanz wurde in den USA im Jahr 2008 und in der Schweiz 2010 zugelassen. (de) Clevidipine (INN, trade name Cleviprex) is a dihydropyridine calcium channel blocker indicated for the reduction of blood pressure when oral therapy is not feasible or not desirable. Clevidipine is used IV only and practitioners titrate this drug to lower blood pressure. It has a half-life of approximately one minute. It is rapidly inactivated by esterases. It was approved by the United States Food and Drug Administration on August 1, 2008. (en) La clévidipine est un inhibiteur calcique de type dihydropyridine, utilisé comme médicament intraveineux dans les poussées hypertensives. (fr) Klewidypina (łac. clevidipinum) – wielofunkcyjny organiczny związek chemiczny z grupy pirydyn, lek stosowany w leczeniu nadciśnienia tętniczego, o działaniu blokującym kanały wapniowe typu L. Jest związkiem chiralnym, produkt farmaceutyczny jest mieszaniną racemiczną obu enancjomerów. (pl) |
| dbo:alternativeName |
Cleviprex (en) |
| dbo:bioavailability |
100.000000 (xsd:float) |
| dbo:casNumber |
167221-71-8 |
| dbo:chEMBL |
1237132 |
| dbo:fdaUniiCode |
19O2GP3B7Q |
| dbo:pubchem |
153994 |
| dbo:thumbnail |
wiki-commons:Special:FilePath/(RS)-Clevidipin_Structural_Formula_V1.svg?width=300 |
| dbo:wikiPageExternalLink |
http://ir.themedicinescompany.com/phoenix.zhtml%3Fc=122204&p=irol-newsArticle&ID=1182776&highlight= http://www.cleviprex.com/pdfs/cleviprex-us-prescribing-information-nov-fda-approved.pdf https://web.archive.org/web/20160309003355/http:/www.cleviprex.com/pdfs/cleviprex-us-prescribing-information-nov-fda-approved.pdf |
| dbo:wikiPageID |
17343462 (xsd:integer) |
| dbo:wikiPageLength |
14739 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1098432804 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbr:Cardiac_surgery dbr:Preload_(cardiology) dbr:Blood_pressure dbr:Aortic_stenosis dbr:Renal_disorder dbr:Cytochrome_P450 dbr:Intravenous_therapy dbr:Pseudocholinesterase_deficiency dbr:Racemic_mixture dbc:Carboxylate_esters dbc:Chloroarenes dbc:Dihydropyridines dbr:Congestive_heart_failure dbr:Esterase dbr:Myocardial_infarction dbr:Contractility dbr:Coronary_sinus dbr:Coronary_steal dbr:Photodegradation dbr:Calcium_channel_blocker dbr:Stroke dbc:Formals dbr:Clinical_trial dbr:Emergency_department dbr:Feces dbr:Clearance_(medicine) dbr:Phospholipid dbr:Triglyceride dbc:Butyrate_esters dbr:Heart_rate dbr:Acute_pancreatitis dbc:Calcium_channel_blockers dbr:Food_and_Drug_Administration dbr:Nitroglycerin dbr:Cardiac_muscle dbr:Half-life dbr:International_Nonproprietary_Name dbr:Hyperlipidemia dbr:Hypotension dbr:Lactic_acid dbr:IV_infusion dbr:Sodium_hydroxide dbr:Sodium_nitroprusside dbr:Glycerin dbr:Inotrope dbr:Nicardipine dbr:Mean_arterial_pressure dbr:Systemic_vascular_resistance dbr:Systolic_blood_pressure dbr:Urine dbr:Vascular_smooth_muscle dbr:Vital_signs dbr:Phases_of_clinical_research dbr:Intravenous_administration dbr:Lipoid_nephrosis dbr:Myocardial_ischemia dbr:Antihypertensive dbr:Aseptic_technique dbr:Racemate dbr:Conduction_(cardiology) dbr:Rebound_hypertension dbr:Reflex_tachycardia dbr:Beta-blocker dbr:Hepatic_dysfunction dbr:File:(R)-Clevidipin_Structural_Formula_V1.svg dbr:File:(S)-Clevidipin_Structural_Formula_V1.svg dbr:File:Cleviprex_50ml_100ml_vial.jpg |
| dbp:atcPrefix |
8.0 (dbd:nicaraguanCórdoba) |
| dbp:atcSuffix |
CA16 (en) |
| dbp:bioavailability |
100.0 (dbd:perCent) |
| dbp:c |
21 (xsd:integer) |
| dbp:casNumber |
167221 (xsd:integer) |
| dbp:chembl |
1237132 (xsd:integer) |
| dbp:chemspiderid |
135722 (xsd:integer) |
| dbp:chirality |
dbr:Racemic_mixture |
| dbp:cl |
2 (xsd:integer) |
| dbp:dailymedid |
Clevidipine (en) |
| dbp:eliminationHalfLife |
60.0 (dbd:second) |
| dbp:excretion |
dbr:Feces dbr:Urine |
| dbp:h |
23 (xsd:integer) |
| dbp:image |
Clevidipine 3D.png (en) |
| dbp:iupacName |
-5 (xsd:integer) |
| dbp:legalEu |
Rx-only (en) |
| dbp:legalUs |
Rx-only (en) |
| dbp:metabolism |
Blood and tissue esterases (en) |
| dbp:n |
1 (xsd:integer) |
| dbp:o |
6 (xsd:integer) |
| dbp:proteinBound |
>99.5% (en) |
| dbp:pubchem |
153994 (xsd:integer) |
| dbp:routesOfAdministration |
dbr:Intravenous_therapy |
| dbp:smiles |
O=C\C1=CC (en) |
| dbp:tradename |
Cleviprex (en) |
| dbp:unii |
19 (xsd:integer) |
| dbp:wikiPageUsesTemplate |
dbt:Calcium_channel_blockers dbt:Cite_journal dbt:Cite_web dbt:Drugbox dbt:Refbegin dbt:Refend dbt:Reflist dbt:Cascite dbt:Fdacite dbt:Drugs.com |
| dct:subject |
dbc:Carboxylate_esters dbc:Chloroarenes dbc:Dihydropyridines dbc:Formals dbc:Butyrate_esters dbc:Calcium_channel_blockers |
| gold:hypernym |
dbr:Blocker |
| rdf:type |
owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:WikicatCalciumChannelBlockers yago:WikicatMolecularFormulas yago:Abstraction100002137 yago:Athlete109820263 yago:Blocker109860248 yago:CausalAgent100007347 yago:Communication100033020 yago:Contestant109613191 yago:FootballPlayer110101634 yago:Formula106816935 yago:LivingThing100004258 yago:Message106598915 yago:MolecularFormula106817173 yago:Object100002684 yago:Organism100004475 yago:Person100007846 yago:PhysicalEntity100001930 yago:Player110439851 yago:YagoLegalActor yago:YagoLegalActorGeo dbo:Drug yago:Statement106722453 yago:Whole100003553 umbel-rc:DrugProduct |
| rdfs:comment |
Clevidipin ist ein Arzneistoff (ein Dihydropyridin-L-Typ-Calciumkanalblocker) aus der Gruppe der Calciumantagonisten zur raschen Reduktion eines erhöhten Blutdrucks in perioperativen Situationen. Die Substanz wurde in den USA im Jahr 2008 und in der Schweiz 2010 zugelassen. (de) Clevidipine (INN, trade name Cleviprex) is a dihydropyridine calcium channel blocker indicated for the reduction of blood pressure when oral therapy is not feasible or not desirable. Clevidipine is used IV only and practitioners titrate this drug to lower blood pressure. It has a half-life of approximately one minute. It is rapidly inactivated by esterases. It was approved by the United States Food and Drug Administration on August 1, 2008. (en) La clévidipine est un inhibiteur calcique de type dihydropyridine, utilisé comme médicament intraveineux dans les poussées hypertensives. (fr) Klewidypina (łac. clevidipinum) – wielofunkcyjny organiczny związek chemiczny z grupy pirydyn, lek stosowany w leczeniu nadciśnienia tętniczego, o działaniu blokującym kanały wapniowe typu L. Jest związkiem chiralnym, produkt farmaceutyczny jest mieszaniną racemiczną obu enancjomerów. (pl) |
| rdfs:label |
Clevidipine (en) Clevidipin (de) Clévidipine (fr) Klewidypina (pl) |
| owl:sameAs |
freebase:Clevidipine yago-res:Clevidipine wikidata:Clevidipine dbpedia-de:Clevidipine dbpedia-fa:Clevidipine dbpedia-fr:Clevidipine dbpedia-pl:Clevidipine dbpedia-ro:Clevidipine dbpedia-sh:Clevidipine dbpedia-sr:Clevidipine https://global.dbpedia.org/id/4i19n |
| prov:wasDerivedFrom |
wikipedia-en:Clevidipine?oldid=1098432804&ns=0 |
| foaf:depiction |
wiki-commons:Special:FilePath/(R)-Clevidipin_Structural_Formula_V1.svg wiki-commons:Special:FilePath/(RS)-Clevidipin_Structural_Formula_V1.svg wiki-commons:Special:FilePath/(S)-Clevidipin_Structural_Formula_V1.svg wiki-commons:Special:FilePath/Clevidipine_3D.png wiki-commons:Special:FilePath/Cleviprex_50ml_100ml_vial.jpg |
| foaf:isPrimaryTopicOf |
wikipedia-en:Clevidipine |
| is dbo:wikiPageRedirects of |
dbr:C21H23Cl2NO6 dbr:ATC_code_C08CA16 dbr:ATCvet_code_QC08CA16 dbr:Clevidipine_butyrate dbr:Cleviprex |
| is dbo:wikiPageWikiLink of |
dbr:Antihypertensive_drug dbr:Calcium_channel_blocker dbr:C21H23Cl2NO6 dbr:Dihydropyridine_calcium_channel_blockers dbr:ATC_code_C08CA16 dbr:ATCvet_code_QC08CA16 dbr:ATC_code_C08 dbr:Retrometabolic_drug_design dbr:List_of_drugs:_Cj–Cl dbr:Clevidipine_butyrate dbr:Cleviprex |
| is foaf:primaryTopic of |
wikipedia-en:Clevidipine |
